Robert Mennel
- Cancer Research top 0.2%
- Breast Cancer Treatment Studies 12
- Oncology top 0.5%
- Cancer Treatment and Pharmacology 14
- HER2/EGFR in Cancer Research 8
- Colorectal Cancer Treatments and Studies 5
- Vascular Tumors and Angiosarcomas 4
-
- Sarcoma Diagnosis and Treatment 7
-
- Lymphoma Diagnosis and Treatment 7
- Genetics top 2%
-
- Chemotherapy-related skin toxicity 7
- Co-authors
- Robert C. BastPeter M. RavdinDaniel F. HayesHerbert A. FritscheMark R. SomerfieldLyndsay N. HarrisSheila E. TaubeLarry Norton
- Journals
- Journal of Clinical Oncology (18 papers)Molecular Therapy (3 papers)Clinical Breast Cancer (3 papers)
- Partner nations
- United StatesItalyCanada
In The Last Decade
Robert Mennel
45 papers receiving 6.4k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Cancer Research 3.3k
- Oncology 4.2k
- Pulmonary and Respiratory Medicine 1.2k
- Pathology and Forensic Medicine 681
- Genetics 952
Countries citing papers authored by Robert Mennel
This map shows the geographic impact of Robert Mennel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Mennel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Mennel more than expected).
Fields of papers citing papers by Robert Mennel
This network shows the impact of papers produced by Robert Mennel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Mennel. The network helps show where Robert Mennel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert Mennel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 21 | |
| 2 | Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guidelinebreakdown → | 2016 | 576 |
| 3 | 2015 | 48 | |
| 4 | 2015 | 14 | |
| 5 | 2012 | 9 | |
| 6 | 2011 | 13 | |
| 7 | 2009 | 400 | |
| 8 | 2009 | 1 | |
| 9 | 2008 | 12 | |
| 10 | American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancerbreakdown → | 2007 | 1670 |
| 11 | 2005 | 32 | |
| 12 | 2003 | 49 | |
| 13 | 1998 | 188 | |
| 14 | Tumor Marker Utility Grading System: a Framework to Evaluate Clinical Utility of Tumor Markersbreakdown → | 1996 | 553 |
| 15 | 1996 | 18 | |
| 16 | 1996 | 34 | |
| 17 | 1993 | 153 | |
| 18 | 1993 | 9 | |
| 19 | 1991 | 32 | |
| 20 | 1988 | 3 |
About Robert Mennel
Robert Mennel is a scholar working on Oncology, Cancer Research, Dermatology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 47 papers that have together received 6.7k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (14 papers), Breast Cancer Treatment Studies (12 papers), HER2/EGFR in Cancer Research (8 papers), Chemotherapy-related skin toxicity (7 papers), Sarcoma Diagnosis and Treatment (7 papers), Lymphoma Diagnosis and Treatment (7 papers), Colorectal Cancer Treatments and Studies (5 papers) and Vascular Tumors and Angiosarcomas (4 papers). The work is most often cited by research in Cancer Research (3.3k citations), Oncology (4.2k citations), Pulmonary and Respiratory Medicine (1.2k citations), Pathology and Forensic Medicine (681 citations) and Genetics (952 citations). Robert Mennel has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Robert C. Bast, Peter M. Ravdin, Daniel F. Hayes, Herbert A. Fritsche, Mark R. Somerfield, Lyndsay N. Harris, Sheila E. Taube, Larry Norton, Stephen E. Jones and J. Milburn Jessup. Their work appears in journals such as Journal of Clinical Oncology, Molecular Therapy, Clinical Breast Cancer, Cancer and The American Journal of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.